RT Journal Article
SR Electronic
T1 A demonstration of cone function plasticity after gene therapy in achromatopsia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.16.20246710
DO 10.1101/2020.12.16.20246710
A1 Mahtab Farahbakhsh
A1 Elaine J. Anderson
A1 Andy Rider
A1 John A. Greenwood
A1 Nashila Hirji
A1 Serena Zaman
A1 Pete R. Jones
A1 D. Samuel Schwarzkopf
A1 Geraint Rees
A1 Michel Michaelides
A1 Tessa M. Dekker
YR 2020
UL http://medrxiv.org/content/early/2020/12/23/2020.12.16.20246710.abstract
AB Achromatopsia (ACHM) is an inherited retinal disease characterised by complete loss of cone photoreceptor function from birth. In recent years, gene therapies have successfully been used to induce signal processing in dormant cones in animal models of ACHM, with greater functional benefits for younger animals. With several completed or on-going clinical trials of gene therapy for ACHM, preliminary evidence suggests that effects on visual function in adults with ACHM may be subtle. Given the known constraints of age on neural plasticity, it is possible that gene therapy earlier in life will have a greater impact. Sensitive, child-friendly tests of cone function are therefore needed to facilitate the optimisation of these treatment strategies. Here, we present a new method that leverages a multimodal approach, linking psychophysical estimates of cone function to cone-mediated signals in visual cortex, measured using fMRI. In a case study of two children with ACHM undergoing gene therapy, we find individual differences in recovery of cone function over time, with one child demonstrating strong concurrent evidence of improved cone function, and retinotopically organised responses in visual cortex to cone-selective stimuli. Integrated fMRI and psychophysical measures may provide insight into the utility of new sight-rescuing therapies at different stages of human development.Competing Interest StatementMM declares financial interest in MeiraGtxClinical TrialPatients were enrolled in clinical trials NCT03758404 and NCT03001310. Data collection for this MRI study had stand-alone ethics approval, from the national ethics committee for patients (#MICM1007) and the UCL ethics committee for normal sighted control participants (#4846/001).Funding StatementThe research was supported by grants from the National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, the European Social Research Council (#ES/N000838/1); MeiraGTx, Retina UK, Moorfields Eye Hospital Special Trustees, Moorfields Eye Charity (R160035A, R190029A, R180004A), Foundation Fighting Blindness (USA) and The Wellcome Trust (099173/Z/12/Z, 100227), Ardalan Family Scholarship, the Persia Educational Foundation Maryam Mirzakhani Scholarship; and the Sir Richard Stapley Educational Trust (#313812). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval for study protocol was approved from the UCL research ethics committee and the NHS Research Ethics Committee (reference #4846/001 and #MICM1007, respectively)All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo data is currently made available.